ADIPOQ and metabolic disease: Furthermore, antigen re-challenge led to downregulation of several metabolic pathways (including lipid biosynthesis and cholesterol and long-chain fatty-acyl-CoA metabolic processes) as well as to a detectable reduction in serum levels of adiponectin and cholesterol, further highlighting the potential role memory T cells play in metabolic disease.